Observational study / 2003
Low vitamin D and high parathyroid hormone levels were linked to an increased risk of sarcopenia in older adults.
In the Longitudinal Aging Study Amsterdam, researchers investigated whether baseline serum 25-hydroxyvitamin D (25-OHD) and parathyroid hormone (PTH) were associated with sarcopenia over 3 years in adults aged 65 and older. After adjustment for confounders, participants with low baseline 25-OHD (<25 nmol/liter) were 2.57 (95% CI 1.40-4.70, based on grip strength) and 2.14 (95% CI 0.73-6.33, based on muscle mass) times more likely to experience sarcopenia compared to those with high levels (>50 nmol/liter). High PTH levels (≥4.0 pmol/liter) were associated with an increased risk of sarcopenia compared with low PTH (<3.0 pmol/liter) based on grip strength (OR 1.71, 95% CI 1.07-2.73) and muscle mass (OR 2.35, 95% CI 1.05-5.28). Associations were similar in men and women.
Shows an association, not proof of cause and effect.
- Study type
- Prospective cohort study
- Who was studied
- Men and women aged 65 years and older (n=1008 for grip strength, n=331 for muscle mass)
- What was measured
- Sarcopenia (loss of grip strength >40% or loss of muscle mass >3%) over 3 years
THE PAPER
Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam.
Visser M, Deeg DJ, Lips P, Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab, 2003.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.